- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans
Authors
Keywords
-
Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume -, Issue -, Pages 0271678X2110310
Publisher
SAGE Publications
Online
2021-07-14
DOI
10.1177/0271678x211031035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
- (2020) Renaud La Joie et al. Science Translational Medicine
- Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease
- (2020) Rik Ossenkoppele et al. JAMA Neurology
- Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation
- (2020) Ya Su et al. JOURNAL OF ALZHEIMERS DISEASE
- 18F-MK-6240 PET for early and late detection of neurofibrillary tangles
- (2020) Tharick A Pascoal et al. BRAIN
- Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
- (2020) Elizabeth C. Mormino et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease
- (2020) Mark E. Schmidt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
- (2020) Matthias Brendel et al. JAMA Neurology
- Longitudinal tau accumulation and atrophy in aging and alzheimer disease
- (2019) Theresa M. Harrison et al. ANNALS OF NEUROLOGY
- Tau PET imaging in neurodegenerative tauopathies—still a challenge
- (2019) Antoine Leuzy et al. MOLECULAR PSYCHIATRY
- Effect of off-target binding on 18F-Flortaucipir variability in healthy controls across the lifespan
- (2019) Suzanne L Baker et al. JOURNAL OF NUCLEAR MEDICINE
- Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer
- (2019) Frederik J. R. Rombouts et al. JOURNAL OF MEDICINAL CHEMISTRY
- Progressive tau accumulation in Alzheimer’s disease: two-year follow-up study
- (2019) Hanna Cho et al. JOURNAL OF NUCLEAR MEDICINE
- Alzheimer’s pathology targets distinct memory networks in the ageing brain
- (2019) Anne Maass et al. BRAIN
- [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease
- (2019) Sandra Sanabria Bohórquez et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
- (2019) Heiko Kroth et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
- (2019) Clifford R. Jack et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
- (2019) Bernard J. Hanseeuw et al. JAMA Neurology
- Tau-positron emission tomography correlates with neuropathology findings
- (2019) Val J. Lowe et al. Alzheimers & Dementia
- Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
- (2019) Ruben Smith et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of dosimetry, quantitative methods and test-retest variability of 18F-PI-2620 PET for the assessment of tau deposits in the human brain
- (2019) Santiago Bullich et al. JOURNAL OF NUCLEAR MEDICINE
- Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
- (2019) Tobey J Betthauser et al. BRAIN
- In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls
- (2018) Tobey J Betthauser et al. JOURNAL OF NUCLEAR MEDICINE
- First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948
- (2018) Dean F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Brain morphology, cognition, and β-amyloid in older adults with superior memory performance
- (2018) Theresa M. Harrison et al. NEUROBIOLOGY OF AGING
- Scan-time Corrections for 80-100 Minute Standardized Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging
- (2018) Mark He et al. IEEE TRANSACTIONS ON MEDICAL IMAGING
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of18F-RO-948 (18F-RO6958948) for quantitative assessment of tau accumulation in the human brain with positron emission tomography
- (2018) Hiroto Kuwabara et al. JOURNAL OF NUCLEAR MEDICINE
- Off-Target18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation
- (2017) Jae Yong Choi et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
- (2017) Marta Marquié et al. Acta Neuropathologica Communications
- Differential Incorporation of Tau Isoforms in Alzheimer's Disease
- (2017) Marisol Espinoza et al. JOURNAL OF ALZHEIMERS DISEASE
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
- (2016) Rik Ossenkoppele et al. BRAIN
- Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
- (2016) Abbas M. Walji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reference Tissue–Based Kinetic Evaluation of 18 F-AV-1451 for Tau Imaging
- (2016) Suzanne L. Baker et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
- (2016) E. D. Hostetler et al. JOURNAL OF NUCLEAR MEDICINE
- [18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy
- (2016) Jennifer L. Whitwell et al. MOVEMENT DISORDERS
- Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy
- (2016) Hanna Cho et al. MOVEMENT DISORDERS
- Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy
- (2016) Ruben Smith et al. MOVEMENT DISORDERS
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
- (2015) Sylvia Villeneuve et al. BRAIN
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
- (2014) H. Hashimoto et al. JOURNAL OF NUCLEAR MEDICINE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started